MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.97−0.08 (-3.90%)
Close on Nov 18, 2026Market cap $125.49MP/E –Yield –
MacroGenics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
MacroGenics's shares outstanding was 64M at Jun 30, 2026. For fiscal 2025 it was 63M, up 0.9% from the year before. Over ten years it grew 7.1% a year on average. The highest annual figure on record is 63M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 63M | +0.9% |
| FY2024 | Dec 31, 2024 | 63M | +1.1% |
| FY2023 | Dec 31, 2023 | 62M | +0.8% |
| FY2022 | Dec 31, 2022 | 61M | +2.5% |
| FY2021 | Dec 31, 2021 | 60M | +14.3% |
| FY2020 | Dec 31, 2020 | 52M | +9.1% |
| FY2019 | Dec 31, 2019 | 48M | +17.5% |
| FY2018 | Dec 31, 2018 | 41M | +13.4% |
| FY2017 | Dec 31, 2017 | 36M | +4.1% |
| FY2016 | Dec 31, 2016 | 35M | +9.1% |
| FY2015 | Dec 31, 2015 | 32M | +16.1% |
| FY2014 | Dec 31, 2014 | 27M | +299.9% |
| FY2013 | Dec 31, 2013 | 7M | +532.1% |
| FY2012 | Dec 31, 2012 | 1M | +5.6% |
| FY2011 | Dec 31, 2011 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 64M | +0.7% |
| Q1 FY2026 | Mar 31, 2026 | 63M | +0.8% |
| Q4 FY2025 | Dec 31, 2025 | 63M | +0.8% |
| Q3 FY2025 | Sep 30, 2025 | 63M | +0.7% |
| Q2 FY2025 | Jun 30, 2025 | 63M | +0.8% |
| Q1 FY2025 | Mar 31, 2025 | 63M | +1.1% |
| Q4 FY2024 | Dec 31, 2024 | 63M | +2.2% |
| Q3 FY2024 | Sep 30, 2024 | 63M | +1.0% |
| Q2 FY2024 | Jun 30, 2024 | 63M | +0.6% |
| Q1 FY2024 | Mar 31, 2024 | 62M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | 61M | -0.2% |
| Q3 FY2023 | Sep 30, 2023 | 62M | +1.3% |
| Q2 FY2023 | Jun 30, 2023 | 62M | +1.4% |
| Q1 FY2023 | Mar 31, 2023 | 62M | +0.8% |
| Q4 FY2022 | Dec 31, 2022 | 62M | +0.4% |
| Q3 FY2022 | Sep 30, 2022 | 61M | +0.5% |
| Q2 FY2022 | Jun 30, 2022 | 61M | +2.2% |
| Q1 FY2022 | Mar 31, 2022 | 61M | +7.2% |
| Q4 FY2021 | Dec 31, 2021 | 61M | +9.0% |
| Q3 FY2021 | Sep 30, 2021 | 61M | +12.3% |
| Q2 FY2021 | Jun 30, 2021 | 60M | +20.1% |
| Q1 FY2021 | Mar 31, 2021 | 57M | +16.7% |
| Q4 FY2020 | Dec 31, 2020 | 56M | +14.9% |
| Q3 FY2020 | Sep 30, 2020 | 54M | +11.4% |
| Q2 FY2020 | Jun 30, 2020 | 50M | +2.4% |
| Q1 FY2020 | Mar 31, 2020 | 49M | +7.5% |
| Q4 FY2019 | Dec 31, 2019 | 49M | +15.7% |
| Q3 FY2019 | Sep 30, 2019 | 49M | +15.8% |
| Q2 FY2019 | Jun 30, 2019 | 49M | +15.9% |
| Q1 FY2019 | Mar 31, 2019 | 46M | +23.5% |
| Q4 FY2018 | Dec 31, 2018 | 42M | +14.9% |
| Q3 FY2018 | Sep 30, 2018 | 42M | +14.8% |
| Q2 FY2018 | Jun 30, 2018 | 42M | +17.8% |
| Q1 FY2018 | Mar 31, 2018 | 37M | +5.7% |
| Q4 FY2017 | Dec 31, 2017 | 37M | +5.7% |
| Q3 FY2017 | Sep 30, 2017 | 37M | +5.8% |
| Q2 FY2017 | Jun 30, 2017 | 36M | – |
| Q1 FY2017 | Mar 31, 2017 | 35M | – |
| Q4 FY2016 | Dec 31, 2016 | 35M | – |
| Q3 FY2016 | Sep 30, 2016 | 35M | – |
See a number that looks wrong?